What Biorad Medisys does

Biorad Medisys Private Limited is a Pune-headquartered, founder-led Indian medical device manufacturer founded in 1999 by Mr. J.M. Hegde. The company organizes its portfolio into three wholly-owned divisions: Orthovasive (orthopedic implants for arthroplasty and sports medicine, including the GENIUS Knee System, OURO Golden Knee for nickel/chromium-allergic patients, EXCEL Medial Pivot Knee, and SIGNATURE hip systems), Neurovasive (neurovascular and peripheral vascular intervention devices including flow diverters, carotid stents, and self-expanding metal stents), and Indovasive (gastroenterology and urology endoscopy products including flexible digital ureteroscopes, Thulium Fiber Laser systems, visualization systems, and haemostatic devices). Biorad manufactures at facilities in Pune and Kolar, operates R&D in Bangalore, and maintains a registered office in Mumbai, a regional sales office in New Delhi, and international presence in the USA, UK, and Switzerland, reaching healthcare professionals and hospitals in 100+ countries.

The company generates revenue through hardware sales of these medical devices via direct field sales to healthcare institutions and a distributor network. Its go-to-market is heavily event-driven, with active participation in specialty conferences such as Arab Health, USICON, IOACON, and ISHKS. Its customer base spans orthopedic surgeons, neurovascular and interventional specialists, and gastroenterologists/urologists, with vertical segmentation by clinical specialty. Strategic positioning emphasizes motion preservation in orthopedics, minimally invasive intervention in neurovascular and endoscopy, and — via its 2025 ReShape Lifesciences asset acquisition — a clinical-stage entry into vagus nerve stimulation for diabetes and obesity management, with human trials expected within approximately one year. The company has no disclosed external venture capital or private equity ownership beyond two reported funding rounds, most recently a ~$47.89M Series 4 led by Kotak Alternate Asset Managers in May 2024.

Name

Biorad Medisys

Legal name

Biorad Medisys Private Limited

Website

https://bioradmedisys.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Biorad Medisys is a Pune-based, founder-led Indian medical device manufacturer operating through three divisions — Orthovasive (orthopedic implants), Neurovasive (neurovascular devices), and Indovasive (gastroenterology and urology endoscopy) — selling hardware to hospitals and specialists across 100+ countries.

Ownership category

akta.pro rank

Product category

Orthopedic and Surgical Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)

akta.pro secondary industries

Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB), Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA), Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL)

Keywords

• Orthopedic implants
• Medical device manufacturing
• Knee replacement systems
• Neurovascular devices
• Endoscopic surgical instruments

Headquarters

HQ city

Pune

HQ country

India

HQ region

Asia

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Manufacture and sale of orthopedic implants (knee, hip), neurovascular devices, and gastrointestinal/urology endoscopes and accessories to healthcare institutions and professionals

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Core offering

Biorad Medisys manufactures and supplies medical devices across three specialized divisions: Orthovasive (orthopedic implants including knee and hip replacement systems and sports medicine devices), Neurovasive (neurovascular and peripheral vascular intervention devices such as flow diverters and carotid stents), and Indovasive (gastroenterology and urology endoscopy equipment including ureteroscopes, thulium fiber lasers, and visualization systems). The company designs, develops, and produces these implants and instruments in-house at its manufacturing facilities in Pune and Kolar, India, and distributes them globally to hospitals and healthcare professionals.

Product overview

Biorad Medisys is a medical device manufacturing company organized into three strategic divisions: Orthovasive (orthopedic implants for arthroplasty and sports medicine including knee and hip systems like GENIUS, OURO Golden, EXCEL Medial Pivot, and SIGNATURE hip systems), Neurovasive (neurovascular and peripheral vascular interventions including flow diverters, carotid stents, and self-expanding metal stents), and Indovasive (gastrointestinal and urology endoscopy solutions including ureteroscopes, laser systems, visualization systems, and various endoscopic devices). The company operates across India with manufacturing facilities in Pune, Bangalore, and Kolar, and maintains global presence in the USA, UK, and Switzerland. The company has been innovating healthcare technologies since 1999 with a focus on continuous innovation and patient-centric design.

Differentiator

Problem solved

Functional benefit

Brands

• OURO Golden Knee System: Knee system for patients allergic to Nickel & Chromium
• SIGNATURE Nx Trabecular Titanium Alloy
• SIGNATURE DUO Dual Mobility System
• EXCEL Medial Pivot Knee
• GENIUS Knee System
• EVOCON Progressively Constrained Knee System
• ROTACON Mobile Bearing Constrained Knee System
• Indoscope-Urs
• QUANTINO Thulium Fiber Laser System
• Enli8 Visualisation System
• GLITZ
• EVOLVIA
• Flow Diverter

Products and services

• GENIUS Knee System Knee replacement implant system designed for arthroplasty procedures, developed through in vivo trials starting in 2014.
• OURO Golden Knee System Knee implant designed specifically for patients allergic to Nickel and Chromium.
• EXCEL Medial Pivot Knee Medial pivot knee implant system featuring deep flexion capability for enhanced patient mobility.
• EVOCON Progressively Constrained Knee System Knee implant system providing progressive stability for complex arthroplasty cases.
• ROTACON Mobile Bearing Constrained Knee System Mobile bearing constrained knee implant system designed for improved knee mechanics.
• SIGNATURE Hip Systems Hip replacement implant systems including SIGNATURE NX Cup with Trabecular Titanium alloy and SIGNATURE DUO Dual Mobility System.
• SIGNATURE LRS with Antimicrobial Coating Limb reconstruction system with antimicrobial coating for infection prevention.
• Fixart Arthroscope Arthroscopy device for minimally invasive joint procedures.
• GRAPNEL Unity Adjustable Loop Cortical Fixation Implant Adjustable loop fixation device for soft tissue repair in sports medicine and orthopedic procedures.
• QUANTINO Thulium Fiber Laser System Thulium fiber laser technology system for urological procedures including lithotripsy.
• Enli8 Visualisation System Visualization system for urology and gastroenterology endoscopic procedures.
• GLITZ Direct In-Scope Suction Device Direct In-scope Suction (DISS) device for RIRS (Retrograde Intrarenal Surgery) technique.
• Cholangioscope Endoscopic device for ERCP (Endoscopic Retrograde Cholangiopancreatography) procedures.
• KLOSURE Haemorrhoid Closure Device Haemorrhoid treatment device with band counters and suction functionality.
• BIOQLOT Instant Endoscopic Haemostatic Spray Endoscopic haemostatic spray for immediate bleeding control during GI procedures.
• LITHOFRAG Mechanical Lithotripter Mechanical lithotripter for emergency removal of gall stones during endoscopic procedures.
• EVOLVIA Self-Expanding Metal Stents Self-expanding metal stents for various hollow organ obstructions.
• Flow Diverter Kink-resistant braided metal stent for intracranial aneurysm treatment.
• Carotid Stent Laser-cut Nitinol stent for carotid artery interventions.
• ASD Atrial Septal Device Closure device for atrial septal defects.
• Indoscope-Urs Flexible Digital Ureteroscope Flexible digital ureteroscope for minimally invasive urology procedures.
• INDUS Knee System Knee replacement implant system whose manufacturing rights were acquired in 2008.

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Bio-RadcoreOEM/ Whitelabel/ Licensing Partner · 5 January 2026iMDx partnered with Bio-Rad to support commercial-scale manufacturing of GraftAssureDx test kit. Bio-Rad provides manufacturing capabilities for iMDx's kidney transplant rejection diagnostic product.
• Frid Mind Technologies (FMT)coreStrategic or Co-development Partner · 16 October 2025Biorad Medisys invested in Frid Mind Technologies (FMT) in Belgium to enhance offerings in stroke prevention and rehabilitation technologies as part of their Neurovasive division expansion.
• Motion Informatics LtdcoreTechnology or Integration · 16 October 2025Biorad Medisys acquired a stake in Motion Informatics Ltd in Israel to strengthen their neurovascular and peripheral vascular portfolio with advanced stroke prevention and rehabilitation technologies.
• ReShape LifesciencescoreStrategic or Co-development Partner · 26 June 2025Biorad Medisys acquired assets from ReShape Lifesciences, including vagus nerve stimulation (VNS) technology for diabetes management. This acquisition supports the development of an implantable VNS device for managing blood-glucose levels, improving insulin sensitivity, and aiding in obesity management. Animal trials have been completed with human trials expected to begin by end of next year.
• Vyome TherapeuticsminorStrategic or Co-development Partner · 26 June 2025ReShape Lifesciences announced a merger with Vyome Therapeutics, with Biorad Medisys involved through the asset purchase agreement.

Scale indicators2 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Meril Life Sciences: India-based medical device company with strong orthopedic, cardiovascular, and surgical portfolios; the closest Indian peer to Biorad's three-division medtech platform.
• Penumbra: Specialist in neurovascular and peripheral vascular intervention including flow diverters and stroke thrombectomy — directly comparable to Biorad's Neurovasive division and Flow Diverter product.
• Conmed Corporation: Mid-cap medical device company with orthopedic, general surgery, and GI/endoscopy portfolios that overlap with Biorad's sports medicine, arthroscopy, and GI divisions.

Broad incumbents

• Zimmer Biomet: Global leader in orthopedic joint reconstruction (knee, hip) — directly comparable to Biorad's Orthovasive division with the GENIUS, OURO, EXCEL, and SIGNATURE product lines, but at vastly larger scale.
• Stryker: Multi-specialty medical device leader with significant orthopedic (knees, hips, trauma) and surgical instruments portfolios that overlap with Biorad's orthopedic and endoscopy offerings.
• Smith & Nephew: Global orthopedics, sports medicine, and advanced wound management company — directly comparable to Biorad's arthroplasty and sports medicine lines including GRAPNEL and SIGNATURE systems.
• Medtronic: Diversified medical device leader with major neurovascular (aneurysm, stroke), orthopedic, and surgical portfolios — competes with Biorad across multiple divisions at global scale.
• Boston Scientific: Global medtech with significant peripheral vascular, neurovascular, and endoscopy franchises — directly comparable to Biorad's Neurovasive and Indovasive GI/urology endoscopy portfolios.
• Olympus Corporation: Global leader in GI and urology endoscopy systems, flexible ureteroscopes, and visualization — directly comparable to Biorad's Indovasive division including Indoscope-Urs and Enli8 visualization.

Emerging players

• PolyNovo (or Sterimed/Steris Surgical): Emerging medical device player with growing orthopedics and surgical adjacencies; comparable as a non-incumbent scaling multi-specialty medtech platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Bioradmed_India
• YouTubeyoutube.com/@biorad_medisys
• Facebookfacebook.com/bioradmedisysofficial
• LinkedInin.linkedin.com/company/bioradmedisys
• Instagraminstagram.com/bioradmedisys

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries4 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biorad Medisys